| Abbreviations | Full names |
| α-SMA | α smooth muscle actin |
| ALA | 5-aminolevulinic acid |
| BD | Bowen’s Disease |
| CAFs | Cancer-associated Fibroblasts |
| CM | Conditioned Medium |
| cSCC | Cutaneous squamous cell carcinoma |
| DHF-DA | Dihydro-fluorescein diacetate |
| DMEM | Dulbecco’s modified Eagle’s medium |
| ECM | Extracellular Matrix |
| EMT | Epithelium-to-mesenchymal transition |
| FBS | Fetal Bovine Serum |
| HO-1 | Heme oxygenase-1 |
| IF | Indirect Immunofluorescence |
| MAL | Methyl 5-aminolevulinate |
| PDT | Photodynamic therapy |
| PpIX | Protoporphirin IX |
| R-BD | Resistant to PDT Bowen Disease |
| SBE | Small Binding Elements |
| TGFβ1 | Transforming growth factor β1 |
| TβRII | TGFβ1 type II receptor |
| TβRI | TGFβ1 type I receptor |
| TME | Tumor microenvironment |
| WB | Western blot |